Randomized trial generated a new iPSC line for studying Diamond-Blackfan Anemia Syndrome, indicating its potential as a disease model.
Diamond-Blackfan Anemia Syndrome (DBAS) is a rare inherited bone marrow failure syndrome diagnosed in early childhood, marked by hypoplastic anemia, congenital anomalies, and increased cancer risk. Most cases involve loss-of-function mutations in ribosomal protein genes, disrupting ribosome biogenesis. We generated iPSC line SANi013-A from a patient with a de novo heterozygous RPS26 c.95–98 duplication. Proerythroblasts derived from peripheral blood were reprogrammed using a non-integrating Sendai virus method. The iPSC line SANi013-A displayed a normal karyotype, expressed pluripotency markers, and differentiated into all three germ layers. This line offers a valuable model for studying DBAS pathogenesis, especially erythropoietic defects
No takes yet. Share an insight, caveat, or question.
Clark et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: